VAX-31, a 31-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate, is the Broadest-Spectrum PCV to Enter the Clinic Topline Safety, Tolerability and…
Company Expects to Initiate VAX-31 Phase 1/2 Study in Healthy Adults This Quarter Topline Safety, Tolerability and Immunogenicity Results from VAX-31 Phase 1/2 Study Expected in the Second.
The FCC is considering an inquiry into the impact of internet data caps on consumers. The Federal Communications Commission (FCC) is considering an inquiry into the impact of internet data caps on consumers, according to a document spotted by Ars Technica.